ArticlePloS one2014

NSK-01105, a novel sorafenib derivative, inhibits human prostate tumor growth via suppression of VEGFR2/EGFR-mediated angiogenesis.

Pengfei Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.